CymitQuimica logo
Aurora Kinase

Aurora Kinase

Les inhibiteurs des kinases Aurora ciblent les kinases Aurora, une famille de kinases sérine/thréonine qui jouent un rôle crucial dans la régulation de la mitose. Ces kinases sont essentielles pour l'alignement correct des chromosomes, leur ségrégation et la cytokinèse pendant la division cellulaire. Une activité anormale des kinases Aurora peut entraîner une prolifération cellulaire incontrôlée et le cancer. En inhibant les kinases Aurora, ces composés peuvent induire un arrêt du cycle cellulaire et l'apoptose dans les cellules cancéreuses, ce qui en fait des outils précieux pour la recherche et la thérapie contre le cancer. Chez CymitQuimica, nous offrons une large gamme d'inhibiteurs de kinases Aurora de haute qualité pour soutenir vos recherches sur la régulation du cycle cellulaire, la mitose et l'oncologie.

109 produits trouvés pour "Aurora Kinase"

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
produits par page.
  • Tinengotinib

    CAS :
    Tinengotinib is a multikinase inhibitor that targets a series of kinases , including Aurora kinases A/B, JAK1/2, FGFR1/2/3, VEGFRs, and many other kinases.
    Formule :C20H19ClN6O
    Degré de pureté :99.05%
    Couleur et forme :Solid
    Masse moléculaire :394.86
  • TAK-901

    CAS :
    <p>TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others</p>
    Formule :C28H32N4O3S
    Degré de pureté :99.02% - 99.59%
    Couleur et forme :Solid
    Masse moléculaire :504.64
  • Centrinone

    CAS :
    Centrinone (LCR-263) (LCR-263) is a reversible inhibitor of polo-like kinase 4 (PLK4; Ki:0.16 nM).
    Formule :C26H25F2N7O6S2
    Degré de pureté :98.76%
    Couleur et forme :Solid
    Masse moléculaire :633.65
  • NU6140

    CAS :
    <p>NU6140 is a selective inhibitor of CDK2-cyclin A (IC50, 0.41 μM).</p>
    Formule :C23H30N6O2
    Degré de pureté :98.33%
    Couleur et forme :Solid
    Masse moléculaire :422.52
  • dAURK-4 hydrochloride


    dAURK-4 hydrochloride, a derivative of Alisertib, functions as a potent and selective degrader of AURKA (Aurora A), exhibiting anticancer properties [1].
    Formule :C52H53Cl2FN8O12
    Degré de pureté :99.44%
    Couleur et forme :Solid
    Masse moléculaire :1071.93
  • PROTAC MPS1 degrader 2


    PROTAC MPS1 Degrader 2 (Compound 15) is a potent degrader of monopolar spindle 1 (Mps1, TTK), AURKA, and AURKB with DC50 values of 42.0, 2.1, and 154.0 nM respectively. It is utilized in the research of acute myeloid leukemia.
    Formule :C41H41N11O8S
    Couleur et forme :Solid
    Masse moléculaire :847.90
  • TAS-119

    CAS :
    TAS-119 (TAS-2104) is an orally available, selective and potent inhibitor of Aurora A with an IC50 of 1.0 nM.TAS-119 also inhibits Aurora B with an IC50 of 95
    Formule :C23H22Cl2FN5O3
    Degré de pureté :99.65%
    Couleur et forme :Solid
    Masse moléculaire :506.36
  • JB170

    CAS :
    JB170 is a specific Aurora A degradator. Alisertib and Thalidomide, induces S-phase arrest in cell growth and inhibits the non-catalytic function.
    Formule :C48H44ClFN8O11
    Degré de pureté :99.82%
    Couleur et forme :Solid
    Masse moléculaire :963.36
  • Retreversine

    CAS :
    Retreversine serves as an inactive control counterpart to Reversine, a pioneering class of ATP-competitive Aurora kinase inhibitor.
    Formule :C21H27N7O
    Couleur et forme :Solid
    Masse moléculaire :393.49
  • dAURK-4

    CAS :
    dAURK-4, a derivative of Alisertib, functions as a potent and selective degrader of AURKA (Aurora A), exhibiting anticancer properties [1].
    Formule :C52H52ClFN8O12
    Couleur et forme :Solid
    Masse moléculaire :1035.47
  • AKI603

    CAS :
    AKI603: Aurora A kinase blocker; IC50 12.3 nM; targets BCR-ABL-T315I resistance; halts leukemia cell growth.
    Formule :C19H23N9O2
    Degré de pureté :99.81%
    Couleur et forme :Solid
    Masse moléculaire :409.45
  • CD532 hydrochloride


    CD532 hydrochloride, potent Aurora A inhibitor (IC50=45 nM), hampers MYCN protein, changes AURKA's shape, aids cancer research.
    Couleur et forme :Solid
  • SP-96

    CAS :
    <p>SP-96: Aurora B inhibitor, IC50=0.316 nM, selectively hinders MDA-MD-468 growth, GI50=107 nM, for triple-negative breast cancer research.</p>
    Formule :C25H20FN7O
    Degré de pureté :99.54%
    Couleur et forme :Solid
    Masse moléculaire :453.47
  • CAM2602


    <p>CAM2602 is an inhibitor of Aurora A-TPX2 interaction, demonstrating a binding affinity of 19 nM with Aurora A. This compound has been shown to inhibit the growth of pancreatic cancer cells. In solid tumor xenograft models, CAM2602 increases the proportion of PH3-positive cells while decreasing the ratio of P-Thr288Aurora A-positive cells, ultimately inhibiting tumor growth.</p>
    Couleur et forme :Odour Solid
  • MS44


    MS44 is a potent degrader of aurora kinase B (AURKBPROTAC) with a degradation concentration (DC50) of 103 nM. It effectively and selectively degrades AURKB in a time- and ubiquitin-proteasome system (UPS)-dependent manner, showing specificity for AURKB over AURKA and AURKC. MS44 inhibits the proliferation of various cancer cell lines and strongly induces G2/M arrest. It is useful for studying AURKB-dependent tumors.
    Couleur et forme :Odour Solid
  • SK2187

    CAS :
    SK2187 is a selective degrader of AURKAPROTAC with a DC50 of approximately 10 nM. It exhibits growth-inhibitory effects on NGP cells, with an IC50 value of 101.5 nM. SK2187 is utilized in studies of MYCN-amplified neuroblastoma.
    Formule :C45H49ClFN7O11S
    Couleur et forme :Solid
    Masse moléculaire :950.43
  • dAurAB2


    dAurAB2 is a bifunctional PROTAC capable of effectively degrading Aurora-A and Aurora-B, with DC50 values of 59 nM and 39 nM, respectively. It reduces N-Myc levels in MYCN-amplified IMR32 neuroblastoma cells and is valuable for neuroblastoma research.
    Couleur et forme :Odour Solid
  • GSK-1070916

    CAS :
    GSK-1070916 (GSK-1070916A) is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3.5 nM/6.5 nM.
    Formule :C30H33N7O
    Degré de pureté :99.73%
    Couleur et forme :Solid
    Masse moléculaire :507.63
  • Aurora A inhibitor 3


    <p>Aurora A Inhibitor 3 (Compound 5h) effectively inhibits Aurora-A kinase, exhibiting an IC50 of 0.78 μM, and demonstrates cytotoxicity against MCF-7 and MDA-MB-</p>
    Degré de pureté :98%
    Couleur et forme :Odour Solid
  • JB300

    CAS :
    JB300 is a PROTAC-based compound that serves as a highly selective degrader of Aurora A, with a DC50 of 30 nM. It is utilized in cancer research. JB300 comprises the PROTAC target protein ligand MK-5108 [pink part], E3 ligase ligand Thalidomide-O-COOH [blue part], and PROTAC Linker Boc-NH-PEG2-C2-NH2 [black part]. The conjugate of the E3 ubiquitin ligase ligand and linker is Thalidomide-O-COOH-NH2-C2-PEG2-NH-Boc.
    Formule :C43H45ClFN7O10S
    Couleur et forme :Solid
    Masse moléculaire :906.375
  • Aurora-A ligand 1

    CAS :
    <p>Aurora-A ligand 1 is a potent and selective inhibitor of Aurora-A, exhibiting a dissociation constant (Kd) of 0.85 nM. It serves as a target protein ligand [PROTAC target protein ligand] in the development of PROTAC Aurora-A degraders with antitumor activity. Additionally, Aurora-A ligand 1 is utilized in the synthesis of HLB-0532259, which exhibits antitumor effects against neuroblastoma.</p>
    Formule :C21H23N5O3
    Couleur et forme :Solid
    Masse moléculaire :393.439
  • AURKA against 1


    <p>Compound Ac13, also termed AURKA against 1, acts as an inhibitor of the Aurora kinase (AURKA) with an IC50 of less than 0.5 nM, targeting the acetylation of endogenous lysine (K162) and exhibiting anti-tumor cell proliferation activity. The kinase activity of AURKA, acetylated at K162 and induced by AURKA against 1, is reversibly restored in HCT116 cells transfected with SIRT3.</p>
    Formule :C28H32FN9O2
    Couleur et forme :Solid
    Masse moléculaire :545.61
  • 11α-O-Tigloyl-12β-O-acetyltenacigenin B

    CAS :
    11α-O-Tigloyl-12β-O-acetyltenacigenin B, an ester derivative isolated from Garcinia cambogia (MTC), modulates the antitumor effects of Aurora-A in lymphoma
    Formule :C28H40O7
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :488.61
  • HLB-0532259

    CAS :
    <p>HLB-0532259 is a PROTAC degrader that targets the degradation of Aurora-A and N-Myc. In non-MYCN amplified MCF-7 cells, it degrades Aurora-A with a DC50 of 20.2 nM, and in MYCN amplified SK-N-BE and Kelly cells, it degrades N-Myc with DC50 values of 179 nM and 229 nM, respectively. HLB-0532259 has demonstrated antitumor activity in mouse models. (Pink: ligand for target protein; Black: linker; Blue: ligand for E3 ligaseCereblon)</p>
    Formule :C40H44N8O7
    Couleur et forme :Solid
    Masse moléculaire :748.827
  • PROTAC MPS1 degrader 1


    PROTAC MPS1 degrader 1 (Compound 19) acts as a potent degrader of Monopolar spindle 1 (Mps1, TTK), AURKA, and AURKB, with DC50 values of 17.7, 108.7, and 570.3 nM respectively. It is utilized in the study of acute myeloid leukemia. (Pink: ligand for target protein; Black: linker; Blue: ligand for E3 ligase)
    Formule :C41H46N12O7
    Couleur et forme :Solid
    Masse moléculaire :818.88
  • Barasertib

    CAS :
    AZD1152 is a pro-drug of Barasertib (AZD1152)-hQPA. Which is a highly selective Aurora B inhibitor with IC50 of 0.37 nM in a cell-free assay.
    Formule :C26H31FN7O6P
    Degré de pureté :99.92% - 99.97%
    Couleur et forme :Solid
    Masse moléculaire :587.54
  • SP-146


    <p>SP-146 is a selective, potent and non-ATP-competitive Aurora B inhibitor(IC50 : 0.316 nM).</p>
    Formule :C25H20FN7O
    Degré de pureté :97.82%
    Couleur et forme :Solid
    Masse moléculaire :453.47
  • Hesperadin

    CAS :
    Hesperadin(IC50=250 nM) effectively inhibits Aurora B.
    Formule :C29H32N4O3S
    Degré de pureté :98.04% - 99.44%
    Couleur et forme :Solid
    Masse moléculaire :516.65
  • 7BIO

    CAS :
    <p>7BIO triggers nonapoptotic death, blocks FLT3, DYRK1A/2, Aurora B/C kinases.</p>
    Formule :C16H10BrN3O2
    Degré de pureté :99.67%
    Couleur et forme :Solid
    Masse moléculaire :356.17
  • AT9283

    CAS :
    <p>AT9283 (J-504568) is an effective multi-targeted inhibitor of JAK2(IC50=1.2 nM) and JAK3(IC50=1.1 nM), Aurora A, Aurora B and Abl(T315I).</p>
    Formule :C19H23N7O2
    Degré de pureté :99.83% - 99.98%
    Couleur et forme :Solid
    Masse moléculaire :381.43
  • Ilorasertib

    CAS :
    Ilorasertib (ABT-348) inhibits Aurora kinases A/B/C & RET, PDGFRβ, Flt1 (IC50: 1-120 nM).
    Formule :C25H21FN6O2S
    Degré de pureté :96.17% - 97.49%
    Couleur et forme :Solid
    Masse moléculaire :488.54
  • ZM-447439

    CAS :
    ZM 447439 selectively inhibits Aurora A/B (IC50: 110/130 nM); 8x less effective on MEK1, Src, Lck; minimal impact on CDK1/2/4, Plk1, Chk1.
    Formule :C29H31N5O4
    Degré de pureté :99.11% - 99.59%
    Couleur et forme :Pale Yellow Solid
    Masse moléculaire :513.59
  • AT-9283 HCl

    CAS :
    AT-9283, a multi-targeted kinase inhibitor, is used potentially for the treatment of multiple myeloma.
    Formule :C19H24ClN7O2
    Couleur et forme :Solid
    Masse moléculaire :417.89
  • Aurora kinase inhibitor-3

    CAS :
    Aurora kinase inhibitor-3 (Aurora Kinase Inhibitor III) is a potent inhibitor of Aurora A kinase (IC50 = 42 nM).1 It is selective for Aurora A over BMX, BTK,
    Formule :C21H18F3N5O
    Degré de pureté :98.91%
    Couleur et forme :Solid
    Masse moléculaire :413.4
  • JNJ-7706621

    CAS :
    <p>JNJ-7706621 is a potent aurora kinase inhibitor, and also inhibits CDK1 and CDK2.</p>
    Formule :C15H12F2N6O3S
    Degré de pureté :99.1% - 99.85%
    Couleur et forme :Solid
    Masse moléculaire :394.36
  • SNS-314 Mesylate

    CAS :
    SNS-314 Mesylate (SNS-314) is an effective and specific Aurora A/B/C inhibitor. SNS-314 is less inhibition of Trk A/B, Fms, Flt4, c-Raf, Axl, and DDR2.
    Formule :C18H15ClN6OS2·CH4O3S
    Degré de pureté :99.44% - 99.92%
    Couleur et forme :Solid
    Masse moléculaire :527.04
  • Reversine

    CAS :
    Reversine, a small synthetic purine analogue (2, 6-disubstituted purine), is a potent inhibitior of Aurora A/B/C(IC50s=150-500 nM).
    Formule :C21H27N7O
    Degré de pureté :98% - 99.45%
    Couleur et forme :Solid
    Masse moléculaire :393.49
  • CYC-116

    CAS :
    CYC116 is a potent inhibitor of Aurora A/B with Ki of 8.0 nM/9.2 nM, is less potent to VEGFR2 (Ki of 44 nM), with 50-fold greater potency than CDKs, not active
    Formule :C18H20N6OS
    Degré de pureté :97.36% - 97.59%
    Couleur et forme :Solid
    Masse moléculaire :368.46
  • Alisertib

    CAS :
    Alisertib (MLN 8237) is a specific Aurora A inhibitor (IC50: 1.2 nM). The selectivity of Alisertib(MLN 8237) is >200-fold higher for Aurora A than Aurora B.
    Formule :C27H20ClFN4O4
    Degré de pureté :98.31% - >99.99%
    Couleur et forme :Solid
    Masse moléculaire :518.92
  • PF 477736

    CAS :
    PF 477736 (PF-736,PF-00477736) is a specifc, effective and ATP-competitive Chk1 inhibitor (Ki: 0.49 nM ) and also inhibits FGFR3, Aurora-A, VEGFR2, Flt3, Fms (
    Formule :C22H25N7O2
    Degré de pureté :97.58% - 99.94%
    Couleur et forme :Solid
    Masse moléculaire :419.48
  • TCS7010

    CAS :
    TCS7010 (Aurora A Inhibitor I) is a novel, potent, and selective inhibitor of Aurora A with IC50 of 3.4 nM in a cell-free assay.
    Formule :C31H31ClFN7O2
    Degré de pureté :98.49% - 99.62%
    Couleur et forme :Solid
    Masse moléculaire :588.07
  • Danusertib

    CAS :
    <p>Danusertib (PHA-739358) is a small-molecule 3-aminopyrazole derivative with potential antineoplastic activity.</p>
    Formule :C26H30N6O3
    Degré de pureté :97.88% - 98.79%
    Couleur et forme :White Powder
    Masse moléculaire :474.55
  • KW-2449

    CAS :
    <p>KW-2449 is a multiple-targeted inhibitor, mostly for Flt3, modestly effective to Bcr-Abl, FGFR1, and Aurora A; little inhibitory on PDGFRβ, IGF-1R, EGFR.</p>
    Formule :C20H20N4O
    Degré de pureté :98.43% - 99.69%
    Couleur et forme :Solid
    Masse moléculaire :332.4
  • SNS-314

    CAS :
    <p>SNS-314 inhibits Aurora kinases A and B, blocking cell division in AK-overexpressing tumors.</p>
    Formule :C18H15ClN6OS2
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :430.93
  • CCT 137690

    CAS :
    CCT 137690 is a highly specific and oral-available aurora kinase inhibitor, for aurora A(IC50=15 nM ), B(IC50=25 nM) and C(IC50=19 nM).
    Formule :C26H31BrN8O
    Degré de pureté :98.51% - 99.89%
    Couleur et forme :Solid
    Masse moléculaire :551.48
  • Protein kinase inhibitor 6

    CAS :
    <p>Protein kinase inhibitor 6 is a protein kinase inhibitor.</p>
    Formule :C13H9FN2S
    Degré de pureté :98.01%
    Couleur et forme :Solid
    Masse moléculaire :244.29
  • TAK-632

    CAS :
    TAK-632 is a potent pan-Raf inhibitor.
    Formule :C27H18F4N4O3S
    Degré de pureté :98% - 99.5%
    Couleur et forme :Solid
    Masse moléculaire :554.52
  • MLN8054

    CAS :
    MLN8054 is a potent and selective Aurora A kinase inhibitor with an IC50 of 4 nM.
    Formule :C25H15ClF2N4O2
    Degré de pureté :98.07% - 98.26%
    Couleur et forme :Solid
    Masse moléculaire :476.86
  • BI-847325

    CAS :
    BI-847325 is a selective dual inhibitor of MEK and aurora kinases (AK) with IC50 values of 4 and 15 nM for human MEK2 and AK-C, respectively.
    Formule :C29H28N4O2
    Degré de pureté :97.13% - 97.54%
    Couleur et forme :Solid
    Masse moléculaire :464.56
  • MK-8745

    CAS :
    <p>MK-8745 is a potent and selective Aurora A inhibitor.</p>
    Formule :C20H19ClFN5OS
    Degré de pureté :99.09% - 99.79%
    Couleur et forme :Solid
    Masse moléculaire :431.91